Yale-PCCSM Newsletter
Letter from Naftali Kaminski, MD, Chief of Yale-PCCSM
I am writing to you with a heavy heart because of the invasion of Ukraine. I always hoped that the collective memory of the death and destruction caused in the 20th Century in the same region by expansionism and authoritarianism would serve as a deterrent for wars in the 21st Century. Obviously, they did not. Let’s hope this conflict comes to a rapid, just and peaceful resolution. If you have team members with roots, friends, or family in the region, please convey my solidarity to them.
In the months that passed since our last communication, Connecticut weathered the winter’s COVID-19 surge. Our teams saw over 1,400 patients hospitalized in our MICU and SDU at Yale New Haven Hospital in 10 weeks, from December 1, 2021 to February 14, 2022. We were ready; we increased attending and fellow teams, expanded tele-ICU capacity and added shift commanders, but continued our regular clinical, research, and educational activities with minimal disruption. Our newly opened state-of-the-art Winchester Center for Lung Disease continued to grow, and our research teams excelled in cutting-edge studies, including outcomes and equity; adverse effects of isolation on the elderly; novel mechanisms of long-COVID dyspnea; and the first single-cell atlas of the human COPD lung, among many others.
On a personal note, I’m so proud of my team that I tend to take for granted that they feel acknowledged. This year, I would like to ask you to help me get them recognized by voting for us on the U.S. News & World Report’s Best Hospitals Survey. If you are willing – please vote for Yale New Haven Hospital in the Doximity survey. Reputation means a lot, and recognition means even more – and you can help us.
Lastly, the past two years have been too long. I hope that many of you will be able to attend the American Thoracic Society International Conference in San Francisco – it would be so good to hear great talks and discussions and most importantly to see each other.
Looking forward to us getting together!
Naftali Kaminski, MD
Boehringer Ingelheim Pharmaceuticals, Inc. Endowed Professor of Medicine (Pulmonary) and Pharmacology
Section Chief, Pulmonary, Critical Care & Sleep Medicine, Internal Medicine, Yale School of Medicine
Naftali.Kaminski@yale.edu
Yale-PCCSM Leadership Team
Yale-PCCSM Spotlight
- Today
- Previous 7 Days
- Previous 30 Days
- Select Dates
Kaminski discusses the consortium’s work.
- February 27, 2022
Yale-PCCSM's Dela Cruz and Ferrante are recognized as physician-scientists.
- February 21, 2022
Yale Pulmonologists publish a study that explains why some people experience shortness of breath one year after recovering from a mild case of COVID-19.
- February 16, 2022
Discoveries & Impact highlights select scientific discoveries per section across the Department of Internal Medicine...
- February 14, 2022Source: The Wall Street Journal
Three theories have emerged on what happens in the body during long Covid and its possible causes
- February 13, 2022
The Center for Phage Biology and Therapy at Yale held its launch event on Thursday, January 27, 2022, by hosting a panel discussion on the context of the documentary, Salt In My Soul.
- February 08, 2022
A new study by Yale researchers provides a single-cell resolution profile of the inflammatory severe COVID-19 disease, and the loss of coordination between the innate and adaptive immune response. This loss of coordination has the potential to amplify a person’s immune response to COVID-19, delaying viral clearance.
- January 27, 2022
The Department of Internal Medicine’s Advancement of Clinician-Educator Scholarship (ACES) Faculty Development Program announces its fourth class of participants for the upcoming academic year 2022 - 2023.
- January 27, 2022Source: YaleNews
New Yale research has provided an unprecedented atlas of the cells in the COPD-afflicted lung, identifying those cells and pathways that may contribute to the reduced lung function and inflammation characteristic of COPD — and could lead to new therapies.